Nicole White Biography and Net Worth

Insider of Assembly Biosciences

Nicole White, PhD joined Assembly in 2020 and previously served as the Company’s Senior Vice President, Pharmaceutical Development and Manufacturing. Prior to joining Assembly, she headed up Process Chemistry at Gossamer Bio and led CMC for multiple early and late stage programs in development. Prior to that she held progressive leadership roles at Gilead Sciences to advance multiple programs from Phase 1 through commercial launch and helped guide the drug substance manufacturing and global outsourcing strategy. While at Gilead she contributed to the development and commercial launch of multiple antiviral programs including Harvoni®, Vemlidy® and Vosevi®. Nicole earned a PhD in Organic Chemistry from the University of California, Irvine and a Bachelor of Science degree from the University of California, San Diego.

What is Nicole S. White's net worth?: The estimated net worth of Nicole S. White is at least $354.40 thousand as of November 18th, 2024. Dr. White owns 11,871 shares of Assembly Biosciences stock worth more than $354,397 as of April 1st. This net worth approximation does not reflect any other investments that Dr. White may own. Learn More about Nicole S. White's net worth.
How do I contact Nicole S. White?: The corporate mailing address for Dr. White and other Assembly Biosciences executives is 331 OYSTER POINT BOULEVARD FOURTH FLOOR, SOUTH SAN FRANCISCO CA, 94080. Assembly Biosciences can also be reached via phone at (833) 509-4583 and via email at [email protected]. Learn More on Nicole S. White's contact information.
Has Nicole S. White been buying or selling shares of Assembly Biosciences?: Nicole S. White has not been actively trading shares of Assembly Biosciences within the last three months. Most recently, Nicole S. White sold 40 shares of the business's stock in a transaction on Monday, November 18th. The shares were sold at an average price of $16.29, for a transaction totalling $651.60. Following the completion of the sale, the insider now directly owns 11,871 shares of the company's stock, valued at $193,378.59. Learn More on Nicole S. White's trading history.
Who are Assembly Biosciences' active insiders?: Assembly Biosciences' insider roster includes Jeanette Bjorkquist (Insider), William Delaney (Insider), Michael Houghton (Director), John McHutchison (CEO), Jason Okazaki (CEO), Timothy Springer (Director), and Nicole White (Insider). Learn More on Assembly Biosciences' active insiders.

Nicole S. White Insider Trading History at Assembly Biosciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/18/2024	Sell	40	$16.29	$651.60	11,871
10/3/2024	Sell	157	$14.81	$2,325.17	11,911
4/30/2024	Sell	1,255	$12.71	$15,951.05	13,025
10/3/2023	Sell	157	$9.60	$1,507.20	7,854

Nicole S. White Buying and Selling Activity at Assembly Biosciences

Assembly Biosciences Company Overview

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases. It develops ABI-5366, a long-acting herpes simplex virus (HSV) helicase-primase inhibitor that is in Phase 1a/1b clinical trial to treat recurrent genital herpes; ABI-1179, which is in Phase 1a/1b clinical trial for the treatment of recurrent genital herpes; and ABI-6250, a small molecule orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical trial. The company also develops ABI-4334, a next-generation capsid assembly modulator, which is in Phase 1b clinical trial for the treatment of hepatitis B virus (HBV). In addition, it develops an oral non-nucleoside polymerase inhibitor targeting transplant-related herpesviruses; and a small molecule interferon-a receptor agonist targeting HBV and HDV. The company has collaboration agreements with Gilead Sciences, Inc. and BeiGene, Ltd. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Today's Range

Now: $29.24

$28.05

$30.02

50 Day Range

MA: $27.89

$25.39

$29.95

2 Week Range

Now: $29.24

$7.75

$39.71

Volume

40,048 shs

Average Volume

96,335 shs

Market Capitalization

$463.75 million

P/E Ratio

N/A

Dividend Yield